The Europe sickle cell disease treatment market was valued at US$883.3 million in 2024 and is projected to expand at a 15.7% CAGR, reaching US$2.49 billion by 2033 mordorintelligence.com +10 datamintelligence.com +10 kbvresearch.com +10 . Rapid growth is fueled by breakthroughs in gene therapy—including Casgevy (exa‑cel)—and expanding pharmacotherapy pipelines targeting unmet ... https://www.datamintelligence.com/research-report/europe-sickle-cell-disease-treatment-market